Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients

Pain

Volumn 68, Issue 2-3, 1996, Pages 209-216

  Wolff, Tomas ^a,b   Samuelsson, Håkan ^a   Hedner, Thomas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Anaesthesia   (Sweden)

Author keywords

analgesia; cancer; morphine; morphine metabolites; morphine 3 glucuronide; morphine 6 glucuronide; pain; subcutaneous infusion

Indexed keywords

CREATININE; DRUG METABOLITE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE;

ADULT; AGED; ARTICLE; CANCER PAIN; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, PARENTERAL; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MORPHINE; MORPHINE DERIVATIVES; NEOPLASMS; PAIN;

EID: 0030471828     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(96)03102-8     Document Type: Article

References (36)

1. Abbott, F.V. and Palmour, R.M., Morphine-glucuronide: analgesic effects and receptor binding profile in rats, Life Sci., 43 (1988) 1685-1695.
2. Arnér, S. and Arnér, B., Differential effects of epidural morphine in the treatment of cancer-related pain, Acta Anesthesiol. Scand., 29 (1985) 32-36.
3. Bigler, D., Broen Christensen, C., Eriksen, J. and Jensen, N.H., Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration, Pain, 41 (1990) 15-18.
4. Bowsher, D., Paradoxical pain: when the metabolites of morphine are in the wrong ratio, Br. Med. J., 306 (1993) 473.
5. Van Dongen, R.T.M., Crul, B.J.P., Koopman-Kimenai, P.M. and Vree, T.B., Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine, Br. J. Pharmacol., 38 (1994) 271-273.
6. Gong, Q.L., Hedner, T., Hedner, J., Björkman, R. and Nordberg, G., Antinociceptive and ventilatory effects of the morphine metabolites: morphine-3-glucuronide and morphine-6-glucuronide, Eur. J. Pharmacol., 193 (1991) 47-56.
7. Gong, Q.L., Hedner, J., Björkman, R. and Hedner, T., Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat, Pain, 48 (1992) 249-255.
8. Goucke, C.R., Hackett, L.P. and Ilett, K.F., Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain, Pain, 56 (1994) 144-149.
9. Hand, C.W., Blunnie, W.P., Claffey, L.P., McShane, A.J., McQuay, H.J. and Moore, R.A., Potential analgesic contribution from morphine-6-glucuronide in CSF, Lancet, ii (1987) 1207-1208.
10. Hanna, C.W., Peat, S.J., Woodham, A., Knibb, A. and Fung, C., Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine, Br. J. Anaesth., 64 (1990) 547-550.
11. Karnofsky, D.A., Belmann, W.Q.H., Graver, L.F. and Burchenal, J.H., The use of nitrogen mustards in the palliative treatment of carcinoma, Cancer, 1 (1948) 634-656.
12. Labella, F.S., Pinsky, C. and Havilicek, V., Morphine derrivates with diminished opiate receptor potency show enhanced central excitatory activity, Brain Res., 174 (1979) 263-271.
13. McQuay, H.J., Carroll, D., Faura, C.C., Cacaghan, D.J., Hand, C.W. and Moore, R.A., Oral morphine in cancer pain: influences on morphine and metabolite concentrations, Clin. Pharmacol. Ther., 48 (1990) 236-244.
14. Osborne, R., Thompson, P., Joel, S.P., Trew, D., Patel, N. and Slevin, M.L., The anlgesic activity of morphine-6-glucuronide, Br. J. Clin. Pharmacol., 34 (1992) 130-138.
15. Pacifici, G.M., Säwe, J., Kager, L. and Rane, A., Morphine glucuronidation in the human fetal and adult liver, Eur. J. Clin. Pharmacol., 22 (1982) 553-558.
16. Pasternak, G.W., Bodnar, R.J., Clark, J.A. and Inturrisi, C.E., Morphine-6-glucuronide, a potent mu agonist, Life Sci., 41 (1987) 2845-2949.
17. Paul, D., Standifier, K.M., Inturrisi, C.E. and Pasternak, G.W., Pharmacological characterization of morphine-6-glucuronide, a very potent morphine metabolite, J. Pharmacol. Exp. Ther., 251 (1989) 477-483.
18. Portenoy, R.K., Kahn, E., Layman, M., Lapin, J., Malkin, M.G., Foley, K.M., Thaler, H.T., Cerbone, B.S. and Inturrisi, C.E., Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations, Neurology, 41 (1991) 1457-1461.
19. Portenoy, R.K., Thaler, H.T., Inturrisi, C.E., Friedlander-Klar, H. and Foley, K.M., The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function, Clin. Pharmacol. Ther., 51 (1992) 422-431.
20. Poulain, P., Morgan Ribon, A., Hanks, G.W., Hoskin, P.J., Aheme, G.W. and Chapman, D.J., CSF concentrations of morphine-6-glucuronide after oral administration of morphine, Pain, 41 (1990) 115-116.
21. Samuelsson, H. and Hedner, T., Pain characterization in cancer patients and the analgetic response to epidural morphine, Pain, 46 (1991) 3-8.
22. Samuelsson, H., Hedner, T., Venn, R. and Michalkiewicks, A., CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine, Pain, 52 (1993) 179-185.
23. Samuelsson, H., Malmberg, F., Eriksson, M. and Hedner, T., Outcomes of epidural morphine treatment in cancer pain: 9 years of clinical experience, J. Pain Sympt. Manag., 10 (1995) 105-112.
24. Shimomura, K., Kamata, O., Ueki, S., Oguri, K., Yoshimura, H. and Tsukamoto, H., Analgesic effect of morphine glucuronides, Tohoku J. Exp. Med., 105 (1971) 45-52.
25. Smith, M.T., Watt, J.A. and Cramond, T., Morphine-3-glucuronide: a potent antagonist of morphine analgesia, Life Sci., 47 (1990) 579-585.
26. Svensson, J.O., Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection, J. Chromatogr., 375 (1986) 174-178.
27. Svensson, J.O., Rane, A., Säwe, J. and Sjöqvist. F., Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography, J. Chromatogr., 230 (1982) 427-432.
28. Säwe, J., High-dose morphine and methadone in cancer patients: clinical considerations of oral treatment, Clin. Pharmacokinet., 11 (1986) 67-106.
29. Tiseo, P.I., Thaler, H.T., Lapin, J., Inturrisi, C.E., Portenoy, R.K. and Foley, K.M., Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients, Pain, 61 (1995) 47-54.
30. Thompson, P.I., Joel, S.P., John, L., Wedzicha, J.A., McLean, M. and Slevin, M.L., Respiratory depression following morphine and morphine-6-glucuronide in normal subjects, Br. J. Clin. Pharmacol., 40 (1995) 145-152.
31. Wahlström, A., Winblad, B., Bixo, M. and Rane, A., Human brain metabolism of morphine and naloxone, Pain, 35 (1988) 121-127.
32. Westerling, D., Persson, C. and Höglund, P., Plasma concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide after i.v. and oral administration to healthy volunteers and their relation to some non-analgesic actions, Thesis Lund, (1993) 111-139.
33. Wolff, T., Samuelsson, H. and Hedner, T., Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration, Pain, (1995) in press.
34. Woolf, C.J., Intrathecal high dose morphine produce hyperalgesia in the rat, Brain Res., 209 (1981) 491-495.
35. Yaksh, T.L., Harty, L.G. and Onofrio, B.M., High doses of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications, Anesthesiology, 64 (1986) 590-597.
36. Yoshimura, H., Ida, S., Oguri, K. and Tsukuamoto, H., Biochemical basis for analgesic activity of morphine-6-glucuronide in the brain of rats, Biochem. Pharmacol., 22 (1973) 1423-1430.